Amgen Inc.
RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF
Last updated:
Abstract:
The present invention relates to RNAi constructs for reducing expression of the PNPLA3 gene. Methods of using such RNAi constructs to treat or prevent liver disease, nonalcoholic fatty liver disease (NAFLD) are also described.
Status:
Application
Type:
Utility
Filling date:
12 Dec 2018
Issue date:
13 May 2021